MorphoSys AG | |
Stock Exchange | Other OTC |
EPS |
$2.18 |
Market Cap |
$3.17 B |
Shares Outstanding |
31.81 M |
Public Float |
- |
MorphoSys AG | |
Stock Exchange | Xetra Stock Exchange |
EPS |
EUR1.9 |
Market Cap |
EUR2.85 B |
Shares Outstanding |
31.84 M |
Public Float |
30.96 M |
MorphoSys AG | |
Stock Exchange | SIX Swiss Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
31.81 M |
Public Float |
- |
Address |
SemmelweisstraĆe 7 Planegg Bayern (Bavaria) 82152 Germany |
Employees | - |
Website | http://www.morphosys.de |
Updated | 07/08/2019 |
MorphoSys AG engages in the development of antibodies for therapeutic, diagnostics, and research applications. It operates through the Proprietary Development and Partnered Discovery segments. The Proprietary Development segment combines proprietary research and development of therapeutic compounds. |